Resources

This guideline lists the 13 parameters you must address when applying to add a Trans-Aortic Valve Implantation (TAVI) device to the Prostheses List.

A Budget 2021–22 fact sheet.

This report describes the proceedings of the Revised Benefit Setting and Review Framework Industry Working Group (BSRIWG) over 8 meetings held between April 2018 and February 2020.

These attachments to PHI circular 62/23 are the 2024 private health insurance premium application form and templates.

These guidelines set out how PLAC will operate to deliver on its Terms of Reference.

This document sets out the purpose, roles, function and composition of PLAC.

This Memorandum of Understanding (MoU) between the Minister for Health and Aged care and the Medical Technology Association of Australia.

The executive summary shows the stakeholder views to improvements to the Protheses List (PL) as announced in the 2021–22 Federal Budget.

The purpose of this paper is to clarify details of the government’s decision to better define the PL purpose, definitions, and scope and explore how this might be implemented in delegated legislation and the guidance.

The below data documents detail cardiac implantable electronic devices (CIEDs) that will have their Prostheses List (PL) benefits reduced by 40% of the gap on 1 July 2023.

This report provides an analysis of stakeholder feedback received in response to the Prostheses List Reform Consultation Paper 6b Cost Recovery Arrangements.

The Australian Government is investing $22 million over 4 years to modernise and improve the Prostheses List (PL). This includes addressing issues raised by recent reviews of the scope and operation of PL.

This report provides an analysis of stakeholder feedback requested through webinars and written responses to the Prostheses List reforms consultation paper 4 (a) and 4 (b).

Presentation from the Assisted Reproductive Technology (ART) Sector Introductory Information Session held on 22 August 2023. The presentation provides an overview on clinic, patient and service eligibility, how to register and lodge a claim, and details on the Grant Agreement.

This cost recovery implementation statement describes how the Department of Health and Aged Care recovers the costs of administering the Prescribed List of Benefits for Medical Devices and Human Tissue Products.

This statement describes how the Department of Health recovers the costs of administering the Prostheses List.

This report outlines the pre-listing assessment framework and governance structure for the Prostheses List. It also addresses Ernst & Young, and Adelaide Health Technology Assessment options and recommendations.

This statement describes how the Department of Health recovers the costs of administering the Prostheses List.

Updated final list of general use items from part A to be removed from the Prostheses List which includes data from the published March 2022 PL.

This working group examined opportunities for reform of the prostheses and devices arrangements in the private health insurance sector.

Australian Government response to the recommendations of the evaluation of the National External Breast Prostheses Reimbursement Program – impact evaluation report.

This report provides a framework and proposes options for governance that would align the Prostheses List processes with those of other health technology assessment processes within the Government. It was developed by Adelaide Health Technology Assessment, under the Prostheses List Reform program.